{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T16:07:19Z","timestamp":1769011639097,"version":"3.49.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T00:00:00Z","timestamp":1636588800000},"content-version":"vor","delay-in-days":224,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008732","name":"Uehara Memorial Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008732","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["15H05675"],"award-info":[{"award-number":["15H05675"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.ijrobp.2020.11.035","type":"journal-article","created":{"date-parts":[[2020,11,20]],"date-time":"2020-11-20T21:30:11Z","timestamp":1605907811000},"page":"1359-1367","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Concurrent Chemo-Proton Therapy Using Adaptive Planning for Unresectable Stage 3 Non-Small Cell Lung Cancer: A Phase 2 Study"],"prefix":"10.1016","volume":"109","author":[{"given":"Hiromitsu","family":"Iwata","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Akita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Yamaba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiji","family":"Kunii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osamu","family":"Takakuwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Misuzu","family":"Yoshihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukiko","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichiro","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kensuke","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiyuki","family":"Toshito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Ogino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuta","family":"Shibamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2020.11.035_bib1","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/s41416-018-0243-2","article-title":"A randomised phase II trial of S-1 plus cisplatin versus vinorelbine plus cisplatin with concurrent thoracic radiotherapy for unresectable, locally advanced non-small cell lung cancer: WJOG5008L","volume":"119","author":"Sasaki","year":"2018","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ijrobp.2020.11.035_bib2","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s13014-019-1239-7","article-title":"Comparative efficacy and safety for different chemotherapy regimens used concurrently with thoracic radiation for locally advanced non-small cell lung cancer: A systematic review and network meta-analysis","volume":"14","author":"Liu","year":"2019","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2020.11.035_bib3","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1097\/JTO.0b013e3182307e5a","article-title":"S-1 plus cisplatin with concurrent radiotherapy for locally advanced non-small cell lung cancer: A multi-institutional phase II trial (West Japan Thoracic Oncology Group 3706)","volume":"6","author":"Ichinose","year":"2011","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.ijrobp.2020.11.035_bib4","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s00280-018-3530-y","article-title":"Long-term results of S-1 plus cisplatin with concurrent thoracic radiotherapy for locally advanced non-small-cell lung cancer","volume":"81","author":"Taira","year":"2018","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.ijrobp.2020.11.035_bib5","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0360-3016(00)01546-7","article-title":"Hyperfractionated radiation therapy and concurrent low-dose daily carboplatin\/etoposide with or without weekend carboplatin\/etoposide chemotherapy in stage III non-small-cell lung cancer: A randomized trial","volume":"50","author":"Jeremic","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2020.11.035_bib6","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00066-011-0043-6","article-title":"The combination of hyperthermia or chemotherapy with gimeracil for effective radiosensitization","volume":"188","author":"Takagi","year":"2012","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.ijrobp.2020.11.035_bib7","doi-asserted-by":"crossref","first-page":"3953","DOI":"10.1200\/JCO.2012.41.9820","article-title":"Incorporating bevacizumab and erlotinib in the combined-modality treatment of stage III non-small-cell lung cancer: Results of a phase I\/II trial","volume":"30","author":"Socinski","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2020.11.035_bib8","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S1470-2045(14)71207-0","volume":"16","author":"Bradley","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2020.11.035_bib9","doi-asserted-by":"crossref","unstructured":"Iwata H, Demizu Y, Fujii O, et al. Long-term outcome of proton therapy and carbon-ion therapy for large (T2a-T2bN0M0) non-small-cell lung cancer. J Thorac Oncol 2013;8:726-735.","DOI":"10.1097\/JTO.0b013e318288ab02"},{"key":"10.1016\/j.ijrobp.2020.11.035_bib10","doi-asserted-by":"crossref","first-page":"4707","DOI":"10.1002\/cncr.26080","article-title":"Phase 2 study of high-dose proton therapy with concurrent chemotherapy for unresectable stage III nonsmall cell lung cancer","volume":"117","author":"Chang","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2020.11.035_bib11","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1093\/jrr\/rru034","article-title":"High-dose concurrent chemo-proton therapy for stage III NSCLC: Preliminary results of a phase II study","volume":"55","author":"Oshiro","year":"2014","journal-title":"J Radiat Res"},{"key":"10.1016\/j.ijrobp.2020.11.035_bib12","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2017.2032","article-title":"Proton beam radiotherapy and concurrent chemotherapy for unresectable stage III non-small cell lung cancer: final results of a phase 2 study","volume":"3","author":"Chang","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ijrobp.2020.11.035_bib13","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ijrobp.2016.10.001","article-title":"National cancer database analysis of proton versus photon radiation therapy in non-small cell lung cancer","volume":"97","author":"Higgins","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2020.11.035_bib14","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1200\/JCO.2017.74.0720","article-title":"Bayesian adaptive randomization trial of passive scattering proton therapy and intensity-modulated photon radiotherapy for locally advanced non-small-cell lung cancer","volume":"36","author":"Liao","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2020.11.035_bib15","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ijrobp.2008.07.063","article-title":"Quantification of tumor volume changes during radiotherapy for non-small-cell lung cancer","volume":"74","author":"Fox","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2020.11.035_bib16","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1111\/cas.12955","article-title":"Dose escalation study of proton beam therapy with concurrent chemotherapy for stage III non-small cell lung cancer","volume":"107","author":"Harada","year":"2016","journal-title":"Cancer Sci"},{"key":"10.1016\/j.ijrobp.2020.11.035_bib17","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.ijrobp.2018.03.025","article-title":"Daily image guidance with cone beam computed tomography may reduce radiation pneumonitis in unresectable non-small cell lung cancer","volume":"101","author":"Yegya-Raman","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2020.11.035_bib18","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1093\/jnci\/djr325","article-title":"Sequential vs. concurrent chemoradiation for stage III non-small cell lung cancer: Randomized phase III trial RTOG 9410","volume":"103","author":"Curran","year":"2011","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijrobp.2020.11.035_bib19","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/S0360-3016(00)00420-X","article-title":"A phase II study of paclitaxel, carboplatin, and hyperfractionated radiation therapy for locally advanced inoperable non-small-cell lung cancer (a Vanderbilt Cancer Center Affiliate Network Study)","volume":"47","author":"Choy","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2020.11.035_bib20","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1097\/JTO.0b013e3181753b38","article-title":"Concurrent chemoradiotherapy with cisplatin and vinorelbine for stage III non-small cell lung cancer","volume":"3","author":"Naito","year":"2008","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.ijrobp.2020.11.035_bib21","doi-asserted-by":"crossref","unstructured":"Iwata H, Ogino H, Hashimoto S, et al. Spot scanning and passive scattering proton therapy: relative biological effectiveness and oxygen enhancement ratio in cultured cells. Int J Radiat Oncol Biol Phys 2016;95:95-102.","DOI":"10.1016\/j.ijrobp.2016.01.017"},{"key":"10.1016\/j.ijrobp.2020.11.035_bib22","doi-asserted-by":"crossref","unstructured":"Toshito T, Omachi C, Kibe Y, et al. A proton therapy system in Nagoya Proton Therapy Center. Australas Phys Eng Sci Med 2016;39:645-654.","DOI":"10.1007\/s13246-016-0456-8"},{"key":"10.1016\/j.ijrobp.2020.11.035_bib23","doi-asserted-by":"crossref","unstructured":"Nakajima K, Iwata H, Ogino H, et al. Clinical outcomes of image-guided proton therapy for histologically confirmed Stage I non-small cell lung cancer. Radiat Oncol 2018;13:199.","DOI":"10.1186\/s13014-018-1144-5"},{"key":"10.1016\/j.ijrobp.2020.11.035_bib24","doi-asserted-by":"crossref","unstructured":"Iwata H, Toshito T, Hayashi K, et al. Proton therapy for non-squamous cell carcinoma of the head and neck: planning comparison and toxicity. J Radiat Res 2019;60:612-621.","DOI":"10.1093\/jrr\/rrz036"},{"key":"10.1016\/j.ijrobp.2020.11.035_bib25","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/S0360-3016(00)01555-8","article-title":"Methodologies and tools for proton beam design for lung tumors","volume":"49","author":"Moyers","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2020.11.035_bib26","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.ijrobp.2009.07.1754","article-title":"Use of normal tissue complication probability models in the clinic","volume":"76","author":"Marks","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2020.11.035_bib27","doi-asserted-by":"crossref","first-page":"e495","DOI":"10.1016\/j.cllc.2019.04.003","article-title":"Chemotherapy and radiation versus chemotherapy alone for elderly patients with N3 stage IIIB NSCLC","volume":"20","author":"Qin","year":"2019","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.ijrobp.2020.11.035_bib28","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.ijrobp.2012.02.041","article-title":"Adaptive\/nonadaptive proton radiation planning and outcomes in a phase II trial for locally advanced non-small cell lung cancer","volume":"84","author":"Koay","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2020.11.035_bib29","doi-asserted-by":"crossref","unstructured":"Iwata H, Shuto T, Kamei S, et al. Combined effects of cisplatin and photon or proton irradiation in cultured cells: radiosensitization, patterns of cell death, and cell cycle distribution. J Radiat Res 2020;61:832-841.","DOI":"10.1093\/jrr\/rraa065"},{"key":"10.1016\/j.ijrobp.2020.11.035_bib30","doi-asserted-by":"crossref","first-page":"4947","DOI":"10.1088\/0031-9155\/56\/15\/019","article-title":"Introducing an on-line adaptive procedure for prostate image guided intensity modulate proton therapy","volume":"56","author":"Zhang","year":"2011","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.ijrobp.2020.11.035_bib31","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.ijrobp.2016.01.055","article-title":"First clinical investigation of cone beam computed tomography and deformable registration for adaptive proton therapy for lung cancer","volume":"95","author":"Veiga","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2020.11.035_bib32","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1200\/JCO.2018.78.3134","article-title":"Future of protons depends on precision","volume":"36","author":"Liao","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2020.11.035_bib33","doi-asserted-by":"crossref","first-page":"18","DOI":"10.14338\/IJPT\/18-00029.1","article-title":"Trends and outcomes of proton radiation therapy use for non-small cell lung cancer","volume":"5","author":"Moreno","year":"2018","journal-title":"Int J Part Ther"},{"key":"10.1016\/j.ijrobp.2020.11.035_bib34","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.radonc.2018.10.029","article-title":"Doses of radiation to the pericardium, instead of heart, are significant for survival in patients with non-small cell lung cancer","volume":"133","author":"Xue","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2020.11.035_bib35","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ijrobp.2017.05.014","article-title":"Consensus guidelines for implementing pencil-beam scanning proton therapy for thoracic malignancies on behalf of the PTCOG thoracic and lymphoma subcommittee","volume":"99","author":"Chang","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2020.11.035_bib36","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.semradonc.2017.11.005","article-title":"Robust proton treatment planning: physical and biological optimization","volume":"28","author":"Unkelbach","year":"2018","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2020.11.035_bib37","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1056\/NEJMoa1709937","article-title":"Durvalumab after chemoradiotherapy in stage III non-small-cell lung cancer","volume":"377","author":"Antonia","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2020.11.035_bib38","doi-asserted-by":"crossref","first-page":"423","DOI":"10.3892\/ijmm.2012.1218","article-title":"Programmed cell death-1 deficiency results in atrial remodeling in C57BL\/6 mice","volume":"31","author":"Fu","year":"2013","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.ijrobp.2020.11.035_bib39","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.jtho.2017.12.002","article-title":"PD-1 modulates radiation-induced cardiac toxicity through cytotoxic T lymphocytes","volume":"13","author":"Du","year":"2018","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.ijrobp.2020.11.035_bib40","doi-asserted-by":"crossref","first-page":"e447","DOI":"10.1016\/S1470-2045(18)30457-1","article-title":"Immune checkpoint inhibitors and cardiovascular toxicity","volume":"19","author":"Lyon","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2020.11.035_bib41","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.ijrobp.2020.03.015","article-title":"Hypofractionated proton therapy with concurrent chemotherapy for locally advanced non-small cell lung cancer: A phase I trial from the University of Florida and Proton Collaborative Group","volume":"107","author":"Hoppe","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2020.11.035_bib42","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/j.jtho.2017.07.036","article-title":"Concomitant chemotherapy and radiotherapy with SBRT boost for unresectable stage III non-small cell lung cancer: A phase I study","volume":"12","author":"Higgins","year":"2017","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.ijrobp.2020.11.035_bib43","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1002\/cncr.29882","article-title":"A systematic review of the cost and cost-effectiveness studies of proton radiotherapy","volume":"122","author":"Verma","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2020.11.035_bib44","first-page":"533","article-title":"Measurement and management of health-related quality of life in lung cancer","volume":"2","author":"Davis","year":"2004","journal-title":"Clin Adv Hematol Oncol"},{"key":"10.1016\/j.ijrobp.2020.11.035_bib45","doi-asserted-by":"crossref","first-page":"381","DOI":"10.21037\/atm.2016.09.33","article-title":"Weight gain as a surrogate marker of longer survival in advanced non-small cell lung cancer patients","volume":"4","author":"Topkan","year":"2016","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.ijrobp.2020.11.035_bib46","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.radonc.2009.02.010","article-title":"High-dose radiotherapy or concurrent chemo-radiation in lung cancer patients only induces a temporary, reversible decline in QoL","volume":"91","author":"Pijls-Johannesma","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2020.11.035_bib47","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1001\/jamaoncol.2015.3969","article-title":"Quality of life analysis of a radiation dose-escalation study of patients with non-small-cell lung cancer: A secondary analysis of the Radiation Therapy Oncology Group 0617 randomized clinical trial","volume":"2","author":"Movsas","year":"2016","journal-title":"JAMA Oncol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301620345570?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301620345570?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T09:55:13Z","timestamp":1759744513000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301620345570"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":47,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S0360301620345570"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2020.11.035","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Concurrent Chemo-Proton Therapy Using Adaptive Planning for Unresectable Stage 3 Non-Small Cell Lung Cancer: A Phase 2 Study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2020.11.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}